Clinical aspects: from systemic inflammation to 'immunoparalysis'.
Volk
H D
HD
Institute of Medical Immunology, Humboldt University Berlin, Germany.
Reinke
P
P
Döcke
W D
WD
D000818:Animals; D017951:Antigen Presentation; D017209:Apoptosis; D002986:Clinical Trials as Topic; D003422:Critical Care; D016207:Cytokines / Q000502:physiology; D004195:Disease Models, Animal; D006684:HLA-DR Antigens / Q000276:immunology; D006801:Humans; D007107:Immune System / Q000276:immunology*; D007108:Immune Tolerance; D007159:Immunologic Tests; D007167:Immunotherapy; D007239:Infections / Q000276:immunology*; D007249:Inflammation / Q000276:immunology*; D007375:Interleukin-1 / Q000502:physiology; D016753:Interleukin-10 / Q000502:physiology; D015850:Interleukin-6 / Q000502:physiology; D009000:Monocytes / Q000502:physiology; D009504:Neutrophils / Q000502:physiology; D010587:Phagocytosis; D018805:Sepsis / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology; D014947:Wounds and Injuries / Q000150:complications / Q000276:immunology
D016207:Cytokines; D006684:HLA-DR Antigens; D007375:Interleukin-1; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D016753:Interleukin-10